The moderately fragmented global biological safety testing market holds a number of dominant companies, such as Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., Merck KGaA, Nordic Scientific & Natural Solutions AB, Toxikon Inc., Paragon Bioservices Inc., and Lonza Group. Players such as Charles River Laboratories International Inc., Merck KGaA, and Thermo Fisher Scientific Inc. have preserved a leading role in the global biological safety testing market through consistent product development and technological progression.
According to Transparency Market Research (TMR), the global biological safety testing market is expected to be valued at close to US$3.1 bn by the end of 2024.
Endotoxin, Sterility Tests to Dominate Demand from Global Biological Safety Testing Market
The global biological safety testing market has a number of application sectors, including sterility tests, bioburden tests, adventitious agent detection tests, cell line authentication and characterization, endotoxin tests, residual host contaminant detection tests, and other toxicity and stability tests. Due to the rising attention being paid to patient safety in the healthcare industry, sterility testing and endotoxin testing are likely to dominate demand from the global biological safety testing market in the coming years. The growth of the global biological safety testing market in the endotoxin and sterility testing sector is also aided by the strong emergence of supportive regulatory frameworks.
The key application segments of the global biological safety testing market include vaccines and therapeutics, tissues and tissue products, cellular therapy, blood and blood products, gene therapy, and stem cell products. Of these, the vaccines and therapeutics and blood and blood products industries are likely to remain key consumers in the global biological safety testing market in the coming years due to the rising demand for transfusion of individual blood components as well as whole blood, and the rising dependence on vaccines, which will require steady production and testing of syringes.
The prime geographical segments of the global biological safety testing market are North America, Asia Pacific, and Latin America. North America is the dominant regional market for biological safety testing, while Asia Pacific is expected to play a vital role in the development of the global biological safety testing market in the coming years. The presence of several leading players in the global biological safety testing industry has been immensely helpful for the North America market, which is likely to retain a steady share in the global biological safety testing market in the coming years.
Improvement of Healthcare Infrastructure in Emerging Countries Vital for Biological Safety Testing Market
One of the key drivers for the global biological safety testing market is the steady development of the healthcare infrastructure in emerging economies such as India, China, Mexico, and Brazil. The pharmaceuticals and biopharmaceuticals market has also witnessed steady growth in emerging countries, which is likely to remain a key growth driver for the global biological safety testing market. Governments in these countries have taken on a proactive role in the development of their regional healthcare sector in recent years, which is likely to have a lasting positive impact on the global biological safety testing market. The steady technological development in the global healthcare sector has also been beneficial for the global biological safety testing market, as it has allowed for precise testing through sophisticated tools.
The growing biopharmaceuticals industry and the rising use of biotech techniques in mainstream biological and medical research is another key driver for the global biological safety testing market. This has ameliorated the impact of the ballooning pricing structure of the healthcare sector by keeping the biological safety testing sector up to date in terms of technology. However, the lack of trained professionals could become a concern for the global biological safety testing market in the coming years.
The information in this preview comes from a Transparency Market Research report titled ‘Biological Safety Testing Market (Product Type - Instruments and Reagents & Kits; Test - Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests, and Stability Tests; Application - Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.’
The global biological safety testing market is segmented as follows:
Biological safety testing Market, by Product Type
- Reagent & Kits
Biological safety testing Market, by Test Type
- Endotoxin Tests
- Sterility Tests
- Cell Line Authentication and Characterization Tests
- Bioburden Tests
- Residual Host Contaminant Detection Tests
- Adventitious Agent Detection Tests
- Other Tests (Toxicity tests, Stability tests, etc.)
Biological safety testing Market, By Application
- Vaccines & Therapeutics
- Blood & Blood Products
- Tissue & Tissue Products
- Stem Cell Products
- Gene Therapy
- Cellular Therapy
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453